Nano X Imaging Ltd asset turnover ratio, the ability of Nano X Imaging Ltd's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.08 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as NNOX's position remain challenging.

Within sector 18 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 2197.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NNOX Asset Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Asset Change	-2.25 %	-19.49 %	-25.83 %	-25.83 %	2.05 %
Y / Y Revenue Change	31.46 %	-	-	-	15.47 %
Asset Turnover Ratio (TTM)	0.08	-	-	-	0.05
NNOX's Total Ranking	# 2197	#	#	#	#
Seq. Asset Change	0 %	0 %	0 %	-2.25 %	-17.64 %
Seq. Revenue Change	-	-	-	-	-

Asset Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 19
Healthcare Sector	# 268
Overall Market	# 2197

Asset Turnover Ratio Statistics
High	Average	Low
8.78	5.79	1.24
(Dec 31 2022)		(Dec 31 2021)

NNOX Company Profile • Back to NNOX Efficiency Comparisons • Compare NNOX Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Assets at quarter ending Dec 31 2025
Cellectis S a	0.22	$ 72.949 Millions	$ 332.032 Millions
Ligand Pharmaceuticals Incorporated	0.22	$ 268.087 Millions	$ 1,222.862 Millions
Lexicon Pharmaceuticals Inc	0.22	$ 49.803 Millions	$ 228.542 Millions
Gossamer Bio Inc	0.21	$ 48.471 Millions	$ 225.646 Millions
Xoma Royalty Corporation	0.21	$ 52.149 Millions	$ 243.014 Millions
Maravai Lifesciences Holdings Inc	0.21	$ 184.990 Millions	$ 869.121 Millions
Nektar Therapeutics	0.21	$ 55.232 Millions	$ 261.382 Millions
Cyclerion Therapeutics Inc	0.21	$ 2.074 Millions	$ 9.904 Millions
Coya Therapeutics Inc	0.21	$ 7.946 Millions	$ 38.463 Millions
X4 Pharmaceuticals Inc	0.20	$ 35.113 Millions	$ 172.299 Millions
Marker Therapeutics inc	0.20	$ 3.547 Millions	$ 18.142 Millions
Pacific Biosciences Of California Inc	0.20	$ 159.780 Millions	$ 818.375 Millions
Dariohealth Corp	0.19	$ 21.665 Millions	$ 112.932 Millions
Collplant Biotechnologies Ltd	0.19	$ 2.371 Millions	$ 12.448 Millions
Standard Biotools Inc	0.19	$ 105.648 Millions	$ 560.988 Millions
Adlai Nortye Ltd	0.19	$ 6.472 Millions	$ 34.433 Millions
Editas Medicine Inc	0.19	$ 40.520 Millions	$ 215.630 Millions
Alpha Cognition Inc.	0.19	$ 10.220 Millions	$ 54.941 Millions
60 Degrees Pharmaceuticals Inc	0.18	$ 1.006 Millions	$ 5.554 Millions
Beyond Air Inc	0.18	$ 5.310 Millions	$ 29.801 Millions
Arbutus Biopharma Corp	0.17	$ 14.083 Millions	$ 80.493 Millions
4d Molecular Therapeutics Inc	0.17	$ 85.209 Millions	$ 495.015 Millions
Wave Life Sciences Ltd	0.17	$ 59.102 Millions	$ 355.144 Millions
Moderna Inc	0.16	$ 1,944.000 Millions	$ 12,296.750 Millions
Inspiremd Inc	0.16	$ 8.649 Millions	$ 54.972 Millions
Maxcyte inc	0.15	$ 33.026 Millions	$ 216.424 Millions
Scilex Holding Company	0.15	$ 30.253 Millions	$ 200.898 Millions
Newgenivf Group Limited	0.14	$ 4.726 Millions	$ 32.723 Millions
Skinvisible Inc	0.14	$ 0.020 Millions	$ 0.139 Millions
Lineage Cell Therapeutics Inc	0.14	$ 14.556 Millions	$ 101.194 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.